CVS Corp
(CVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,507,000 | 9,801,000 | 8,196,000 | 13,043,000 | 13,807,000 |
| Marketable Securities | 3,755,000 | 3,288,000 | 3,259,000 | 3,145,000 | 3,080,000 |
| Receivables | 32,385,000 | 32,217,000 | 35,227,000 | 32,927,000 | 29,546,000 |
| Inventories | 16,068,000 | 16,346,000 | 18,025,000 | 17,954,000 | 17,291,000 |
| Other current assets | 5,237,000 | 5,821,000 | 3,151,000 | 3,074,000 | 4,032,000 |
| TOTAL | $69,952,000 | $67,473,000 | $67,858,000 | $70,143,000 | $67,756,000 |
| Non-Current Assets | |||||
| PPE Net | 13,032,000 | 13,037,000 | 13,183,000 | 13,022,000 | 13,001,000 |
| Investments And Advances | 25,028,000 | 24,074,000 | 23,019,000 | 21,667,000 | 22,114,000 |
| Intangibles | 119,583,000 | 120,042,000 | 120,506,000 | 120,885,000 | 121,378,000 |
| Other Non-Current Assets | 24,886,000 | 25,117,000 | 25,162,000 | 25,589,000 | 25,822,000 |
| TOTAL | $182,529,000 | $182,270,000 | $181,870,000 | $181,163,000 | $182,315,000 |
| Total Assets | $252,481,000 | $249,743,000 | $249,728,000 | $251,306,000 | $250,071,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,731,000 | 6,450,000 | 2,972,000 | 2,132,000 | 2,402,000 |
| Accounts payable and accrued liabilities | 52,489,000 | 50,374,000 | 49,820,000 | 48,921,000 | 45,782,000 |
| Accrued Expenses | 21,163,000 | 22,350,000 | 23,515,000 | 22,571,000 | 22,831,000 |
| Other current liabilities | 2,092,000 | 2,239,000 | 1,141,000 | 6,188,000 | 6,485,000 |
| TOTAL | $81,386,000 | $83,319,000 | $79,189,000 | $81,553,000 | $79,206,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 62,643,000 | 57,694,000 | 58,638,000 | 59,782,000 | 61,419,000 |
| Other Non-Current Liabilities | 29,291,000 | 30,385,000 | 30,953,000 | 31,207,000 | 31,843,000 |
| TOTAL | $95,984,000 | $92,274,000 | $93,903,000 | $95,243,000 | $97,863,000 |
| Total Liabilities | $177,370,000 | $175,593,000 | $173,092,000 | $176,796,000 | $177,069,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,257,979 | 1,255,373 | 1,258,450 | 1,286,897 | 1,284,399 |
| Common Shares | 49,371,000 | 49,209,000 | 48,992,000 | 48,829,000 | 48,649,000 |
| Retained earnings | 62,797,000 | 61,873,000 | 61,604,000 | 60,343,000 | 58,868,000 |
| Other shareholders' equity | -138,000 | -159,000 | -122,000 | -831,000 | -582,000 |
| TOTAL | $75,111,000 | $74,150,000 | $76,636,000 | $74,510,000 | $73,002,000 |
| Total Liabilities And Equity | $252,481,000 | $249,743,000 | $249,728,000 | $251,306,000 | $250,071,000 |